Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 39 articles:
HTML format
Text format



Single Articles


    May 2018
  1. GISBERT JP, Chaparro M
    Switching from an originator anti-TNF to a biosimilar in patients with inflammatory bowel disease: Can it be recommended? A systematic review.
    Gastroenterol Hepatol. 2018 May 9. pii: S0210-5705(18)30108.
    PubMed     Text format     Abstract available


  2. RODRIGUEZ-LAGO I, Benitez JM, Garcia-Sanchez V, Gutierrez A, et al
    Granulocyte and monocyte apheresis in inflammatory bowel disease: The patients' point of view.
    Gastroenterol Hepatol. 2018 May 5. pii: S0210-5705(18)30110.
    PubMed     Text format     Abstract available


    April 2018
  3. SUAREZ FERRER C, Poza Cordon J, Cerpa Arencibia A, Sanchez Azofra M, et al
    Perspectiva actual hospitalization in inflammatory bowel disease: Current perspective.
    Gastroenterol Hepatol. 2018 Apr 7. pii: S0210-5705(18)30034.
    PubMed     Text format    


    March 2018
  4. FRAILE LOPEZ M, de Francisco R, Perez-Martinez I, Garcia Garcia B, et al
    Pyoderma gangrenosum and primary cutaneous cryptococcosis in an ulcerative colitis patient.
    Gastroenterol Hepatol. 2018 Mar 5. pii: S0210-5705(18)30050.
    PubMed     Text format    


    February 2018
  5. GOBBO M, Carmona L, Panadero A, Canas M, et al
    The psychosocial impact of inflammatory bowel disease and its management. From the patients' perspective.
    Gastroenterol Hepatol. 2018 Feb 5. pii: S0210-5705(18)30006.
    PubMed     Text format    


    January 2018
  6. BERMEJO F, Aguas M, Chaparro M, Domenech E, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of tiopurines in inflammatory bowel disease.
    Gastroenterol Hepatol. 2018 Jan 18. pii: S0210-5705(17)30248.
    PubMed     Text format     Abstract available


    December 2017
  7. BARREIRO-DE ACOSTA M, Marin-Jimenez I, Panadero A, Guardiola J, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn's Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease pa
    Gastroenterol Hepatol. 2017 Dec 20. pii: S0210-5705(17)30244.
    PubMed     Text format     Abstract available


  8. DE LA PISCINA PR, Delgado E, Duca I, Estrada S, et al
    Acute infection due to Mycobacterium marinum in a patient with ulcerative colitis and metabolic syndrome on infliximab therapy.
    Gastroenterol Hepatol. 2017 Dec 16. pii: S0210-5705(17)30241.
    PubMed     Text format    


    September 2017
  9. GONZALEZ ALAYON C, Pedrajas Crespo C, Marin Pedrosa S, Benitez JM, et al
    Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life.
    Gastroenterol Hepatol. 2017 Sep 9. pii: S0210-5705(17)30189.
    PubMed     Text format     Abstract available


  10. SANZ SANZ J, Juanola Roura X, Seoane-Mato D, Montoro M, et al
    Screening of Inflammatory Bowel Disease and Spondyloarthritis for Referring Patients Between Rheumatology and Gastroenterology.
    Gastroenterol Hepatol. 2017 Sep 4. pii: S0210-5705(17)30184.
    PubMed     Text format     Abstract available


    August 2017
  11. GUERRERO PUENTE L, Iglesias Flores E, Benitez JM, Medina Medina R, et al
    Evolution after switching to biosimilar infliximab in inflammatory bowel disease patients in clinical remission.
    Gastroenterol Hepatol. 2017 Aug 30. pii: S0210-5705(17)30182.
    PubMed     Text format     Abstract available


  12. AGUAS M, Del Hoyo J, Faubel R, Valdivieso B, et al
    Telemedicine in the treatment of patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Aug 7. pii: S0210-5705(17)30166.
    PubMed     Text format     Abstract available


    July 2017
  13. TORRES P, Lobaton T, Canete F, Clos A, et al
    Cytomegalovirus primoinfection in inflammatory bowel disease.
    Gastroenterol Hepatol. 2017 Jul 19. pii: S0210-5705(17)30161.
    PubMed     Text format    


    June 2017
  14. AGUD FERNANDEZ M, Lopez Lopez F, Diaz Pedroche C, Gomez-Martin C, et al
    Concurrent inflammatory bowel disease and gastrointestinal stromal tumor.
    Gastroenterol Hepatol. 2017 Jun 24. pii: S0210-5705(17)30136.
    PubMed     Text format    


  15. DOMENECH E, Lopez-Sanroman A, Nos P, Vera M, et al
    Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the monitoring, prevention and treatment of post-operative recurrence in Crohn's disease.
    Gastroenterol Hepatol. 2017 Jun 9. pii: S0210-5705(17)30126.
    PubMed     Text format     Abstract available


    February 2017
  16. SEBASTIAN DOMINGO JJ
    Review of the role of probiotics in gastrointestinal diseases in adults.
    Gastroenterol Hepatol. 2017 Feb 6. pii: S0210-5705(17)30003.
    PubMed     Text format     Abstract available


    December 2016
  17. MONTESERIN L, Jimenez M, Molina G, Reyes N, et al
    Colonic pseudopolyposis in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016 Dec 21. pii: S0210-5705(16)30161.
    PubMed     Text format    


    September 2016
  18. GARCIA-LOPEZ S
    Inflammatory bowel disease in Digestive Disease Week 2016: advances in epidemiology, follow-up, treatment monitoring, optimisation and individual tailoring, and colon cancer prevention.
    Gastroenterol Hepatol. 2016;39 Suppl 1:29-35.
    PubMed     Text format     Abstract available


  19. CHAPARRO M
    Treatment of inflammatory bowel disease: what's new in Digestive Disease Week 2016.
    Gastroenterol Hepatol. 2016;39 Suppl 1:20-28.
    PubMed     Text format     Abstract available


  20. GOMOLLON F
    Treatment adherence is always worse than we think: an unresolved problem in inflammatory bowel disease.
    Gastroenterol Hepatol. 2016;39 Suppl 1:14-19.
    PubMed     Text format     Abstract available


    May 2016
  21. LOZOYA ANGULO ME, de Las Heras Gomez I, Martinez Villanueva M, Noguera Velasco JA, et al
    [Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders].
    Gastroenterol Hepatol. 2016 May 31. pii: S0210-5705(16)30048.
    PubMed     Text format     Abstract available


  22. COLLAZO DIEGUEZ M, Gonzalez Carrera V
    [Foot drop during adalimumab therapy for Crohn disease].
    Gastroenterol Hepatol. 2016 May 13. pii: S0210-5705(16)30042.
    PubMed     Text format    


    March 2016
  23. MIRANDA-GARCIA P, Chaparro M, Gisbert JP
    Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2016 Mar 25. pii: S0210-5705(16)30001.
    PubMed     Text format     Abstract available


  24. GINARD D, Khorrami S, Perez-Carazo L, Tavio-Hernandez E, et al
    [Efficacy and effectiveness of biologic therapy in inflammatory bowel disease. EFIFECT study].
    Gastroenterol Hepatol. 2016 Mar 18. pii: S0210-5705(16)00090.
    PubMed     Text format     Abstract available


  25. IRIARTE A, Zaera C, Bachiller-Corral J, Lopez-Sanroman A, et al
    [Inflammatory bowel disease as a paradoxical effect of anti-TNF alpha therapy].
    Gastroenterol Hepatol. 2016 Mar 15. pii: S0210-5705(16)00088.
    PubMed     Text format     Abstract available


  26. BATISTA L, Zabana Y, Aceituno M, Esteve M, et al
    Men in the spotlight: A rare case of penile squamous carcinoma associated with human papillomavirus (HPV) infection in a patient with ulcerative colitis (UC).
    Gastroenterol Hepatol. 2016 Mar 3. pii: S0210-5705(16)00037.
    PubMed     Text format    


    February 2016
  27. DOMENECH E, Gisbert JP
    [Efficacy and safety of vedolizumab in the treatment of ulcerative colitis].
    Gastroenterol Hepatol. 2016 Feb 29. pii: S0210-5705(16)00025.
    PubMed     Text format     Abstract available


  28. MUNOZ VILLAFRANCA C, Bravo Rodriguez MT, Ortiz de Zarate J, Arreba Gonzalez P, et al
    [Clinical outcome after discontinuation of infliximab in patients with ulcerative colitis in deep remission].
    Gastroenterol Hepatol. 2016 Feb 29. pii: S0210-5705(16)00026.
    PubMed     Text format     Abstract available


    January 2016
  29. AMO L, Gonzalez-Lama Y, Suarez C, Blazquez I, et al
    [Impact of the incorporation of a nurse in an inflammatory bowel disease unit].
    Gastroenterol Hepatol. 2016 Jan 27. pii: S0210-5705(15)00227.
    PubMed     Text format     Abstract available


    November 2015
  30. CHAPARRO M, Gisbert JP
    [New molecules in the treatment of inflammatory bowel disease].
    Gastroenterol Hepatol. 2015 Nov 26. pii: S0210-5705(15)00244.
    PubMed     Text format     Abstract available


  31. RUIZ-CUESTA P, Gonzalez-Alayon C, Jurado-Garcia J, Iglesias-Flores EM, et al
    Adherence to a predefined vaccination program in patients with inflammatory bowel disease.
    Gastroenterol Hepatol. 2015 Nov 18. pii: S0210-5705(15)00240.
    PubMed     Text format     Abstract available


  32. LOPEZ-IBANEZ M, Marin-Jimenez I
    [Drugs and anti-drug antibody levels in the management of patients with inflammatory bowel disease].
    Gastroenterol Hepatol. 2015 Nov 18. pii: S0210-5705(15)00236.
    PubMed     Text format    


    September 2015
  33. GARCIA-LOPEZ S
    [Epidemiology, follow-up, monitoring and other aspects of inflammatory bowel disease].
    Gastroenterol Hepatol. 2015;38 Suppl 1:32-8.
    PubMed     Text format     Abstract available


  34. CHAPARRO M
    [Natural history, complications, safety and pregnancy in inflammatory bowel disease].
    Gastroenterol Hepatol. 2015;38 Suppl 1:20-31.
    PubMed     Text format     Abstract available


    August 2015
  35. TINOCO R, Garcia E, Ramirez F, Correro F, et al
    [A case of de novo inflammatory bowel disease after liver transplantation for cryptogenic cirrhosis].
    Gastroenterol Hepatol. 2015 Aug 25. pii: S0210-5705(15)00167.
    PubMed     Text format    


  36. SENOSIAIN C, Gonzalez-Tallon A A, Lopez-Sanroman A, Mateos ML, et al
    Hepatitis E seroprevalence in inflammatory bowel disease.
    Gastroenterol Hepatol. 2015 Aug 6. pii: S0210-5705(15)00148.
    PubMed     Text format     Abstract available


    July 2015
  37. ALDEGUER X, Sicras-Mainar A
    Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study.
    Gastroenterol Hepatol. 2015 Jul 23. pii: S0210-5705(15)00110.
    PubMed     Text format     Abstract available


    June 2015
  38. GISBERT JP, Gomollon F, Mendez I
    [Cost-effectiveness assessment through theoretical cost-minimization analysis of the use of two gastro-resistant modified-release mesalazine formulations in the management of ulcerative colitis in Spain].
    Gastroenterol Hepatol. 2015 Jun 10. pii: S0210-5705(15)00117.
    PubMed     Text format     Abstract available


    May 2015
  39. MARIN-JIMENEZ I, Gisbert JP, Perez-Calle JL, Garcia-Sanchez V, et al
    [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort].
    Gastroenterol Hepatol. 2015 May 13. pii: S0210-5705(15)00101.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: